If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Trading Update

15 Jun 2021 07:00

RNS Number : 8629B
K3 Capital Group PLC
15 June 2021
 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries the "Group")

Pre- Close Trading Update

K3 Capital Group plc, a multi-disciplinary professional services firm providing advisory services to SMEs, is pleased to provide a pre-close trading update for the financial year ended 31 May 2021 ("FY21 Financial Year").

The Group delivered an exceptionally strong performance, having successfully grown revenues and profits across all divisions. As a result, the Group expects to report revenues for the full year to 31 May 2021 of approximately £46.0 million and adjusted EBITDA* of not less than £14.25 million. These results exceed the full year guidance provided by the Company in the trading updates released on 14 April 2021 and 4 March 2021, with adjusted EBITDA* significantly ahead of current consensus market expectations**. The M&A division had a strong year with material organic growth delivering revenue and adjusted EBITDA* significantly ahead of expectations and delivering a high profit margin contribution.

Alongside the transformational acquisitions of Quantuma and randd and in line with the Group's stated strategy, three complementary bolt-on acquisitions were also completed during the period and have all contributed to growth and provided further diversification of revenues. These new revenue lines together with the new tax advisory and debt advisory offerings and the newly established Market Mapping joint venture all provide additional layers of diversification and will financially contribute to the Group in FY22 and beyond.

The Group's balance sheet is strong with an unaudited cash balance of approximately £14 million as at 31 May 2021. In addition, shortly before the end of the financial year, the Group announced that it had agreed maiden debt facilities of £15 million, which remain undrawn and give the Company greater flexibility in funding future bolt-on acquisitions.

* Adjusted EBITDA is earnings before interest, tax, depreciation and amortisation, stated before acquisition related costs and share based payment charges.

** Current consensus analyst forecasts for revenue of £45.02 million and adjusted EBITDA of £13.27 million.

John Rigby, K3's CEO, commented,

"In a year of challenging conditions, particularly in the context of the suppressed insolvency market, we are extremely proud that we have delivered results for the FY21 Financial Year that are significantly ahead of initial market expectations; beating multiple upgrades made to market expectations across the year. The FY21 Financial Year has been a transformational and very important year for the Group, notably being our first period of reporting post the acquisitions of Quantuma and randd. It represents a year of significant growth in the scale, diversity and quality or our business which sees a significant increase across revenue and profits as well as progression in our strategy to build a wider group of growing and complementary professional services businesses.

All of our business divisions have performed well and integration projects have proceeded in line with expectations. We believe that these results are testament to the Group's ability to identify, acquire and integrate high quality and accretive acquisitions and we are proud to have built a diverse group of businesses that are positioned to deliver robust performances across all economic cycles.

As ever there remains a degree of uncertainty in the markets in which we operate, however we begin the 2022 financial year with great confidence. Along with investing in the Group to expand the range and depth of our service lines, we have also invested in our internal resource to provide us with the flexibility and capacity to service an increase in demand. Additionally, we continue to identify further opportunities to expand the range and depth of our service lines. In summary, the board is delighted with the performance of the Group and remains confident of continuing its strategy and making further progress in the upcoming financial year."

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information, please contact:

K3 Capital Group plc

Tel: c/o finnCap 020 7220 0500

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

finnCap Ltd (Nominated Adviser and Joint Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Emily Watts, Charlie Beeson (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

 

 

 

Canaccord Genuity Limited (Joint Broker)

Tel: 020 7523 8000

Bobbie Hilliam (Corporate Broking)

Alex Aylen (Head of Equities)

 About K3 Capital

K3 Capital Group plc is a multi-disciplinary professional services firm providing advisory services to SMEs, with operations throughout the UK and overseas.

Services provided by KBS Corporate, KBS Corporate Finance, Knightsbridge and KBS Capital Markets:

· Mergers and Acquisitions (M&A) - Company sales, brokerage and corporate finance services to SME's looking to achieve full or partial exit, advising on sales to private, trade, plc, private equity or overseas acquirors. Strategic advisory and valuations, financial due diligence and debt advisory.

Services provided by RandD UK Limited:

· Research & Development tax credit advisory: advising clients on Research and Development Tax Credit (RDTC) claims.

Services provided by Quantuma Advisory Limited:

· Restructuring advisory: formal insolvency appointments, informal restructuring advisory, personal insolvency and pension restructuring and insolvency advice.

· Financial advisory: comprehensive analysis of business performance through business toolkit, independent reviews, stakeholder management and turnaround and interim support.

· Creditor Services: creditor representation and liquidations.

· Forensic accounting and expert witness: forensic investigations, intelligence and forensic accounting.

· Intax: Tax Investigations relating to tax fraud / tax avoidance / disclosures and code of practice 9 (COP9) related work.

The Group's medium-term strategy is to build a wider group of growing and complementary professional services businesses to provide SME's with high quality advice across specialist disciplines.

K3 Capital Group trades on the London Stock Exchange (AIM: K3C.L), having listed on 11 April 2017. Please visit www.k3capitalgroupplc.com for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVTRDISLIL
Date   Source Headline
7th Sep 20207:00 amRNSInvestor Presentation
7th Aug 20202:36 pmRNSHolding(s) in Company
7th Aug 202011:26 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSAcquisition, Directorate Changes & Results Notice
21st Jul 20204:32 pmRNSHolding(s) in Company
21st Jul 20202:51 pmRNSHolding(s) in Company
20th Jul 20203:51 pmRNSHolding(s) in Company
20th Jul 20202:35 pmRNSHolding(s) in Company
17th Jul 202011:30 amRNSResult of General Meeting
2nd Jul 20205:40 pmRNSHolding(s) in Company
2nd Jul 20205:37 pmRNSHolding(s) in Company
1st Jul 20202:37 pmRNSHolding(s) in Company
1st Jul 202011:59 amRNSHolding(s) in Company
30th Jun 20202:00 pmRNSPosting of Circular and Notice of General Meeting
29th Jun 20202:05 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 20201:25 pmRNSResult of Fundraising
29th Jun 20207:01 amRNSPrimaryBid.com Offers
29th Jun 20207:00 amRNSProposed Fundraising to Raise up to £30.5 million
7th Apr 20204:42 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSTrading Update
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
28th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20203:00 pmRNSDirector/PDMR Shareholding
5th Feb 20202:30 pmRNSDirector/PDMR Shareholding
4th Feb 20207:00 amRNSHalf-year Report
16th Dec 20197:00 amRNSTrading Update
20th Nov 20196:05 pmRNSHolding(s) in Company
18th Oct 20191:30 pmRNSResult of AGM
17th Sep 20191:43 pmRNSFinal Dividend Timetable
17th Sep 20197:00 amRNSNotice of AGM
17th Sep 20197:00 amRNSFinal Results
21st Aug 201910:25 amRNSHolding(s) in Company
17th Jun 201912:00 pmRNSCorrection: Director/PDMR Shareholding
14th Jun 20192:40 pmRNSDirector/PDMR Shareholding
6th Jun 20192:09 pmRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSTrading Update and Notice of Results
16th May 20194:30 pmRNSHolding(s) in Company
8th Apr 201911:41 amRNSHolding(s) in Company
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSHalf-year Report
12th Dec 20187:00 amRNSLeading Advisor in Mid-Market M&A Adviser Rankings
11th Dec 20187:00 amRNSTrading Update
6th Dec 20184:52 pmRNSHolding(s) in Company
11th Oct 201811:05 amRNSSecond Price Monitoring Extn
11th Oct 201811:00 amRNSPrice Monitoring Extension
26th Sep 20185:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.